Genetic Variations of ESR1 Gene are Associated with Bone Mineral Density Traits in Korean Women

  • Jin, Hyun-Seok (Department of Medical Genetics, School of Medicine, Ajou University) ;
  • Eom, Yong-Bin (Department of Biomedical Laboratory Science, Korea Nazarene University)
  • Received : 2012.06.03
  • Accepted : 2012.06.25
  • Published : 2012.09.30

Abstract

Bone mineral density (BMD) is used in the clinical diagnosis of osteoporosis and the assessment of fracture risk. Osteoporosis, characterized mainly by decreased BMD, is a highly heritable complex disorder and a major public health concern to hundreds of millions of elderly persons worldwide. However, the specific genetic variants determining risk for low bone density are still largely unknown. Here, we performed association analysis to elucidate the possible relations of genetic polymorphisms in ESR1 gene with low bone density. By examining genotype data of a total of 1813 women in the Korean Association REsource (KARE) study, we discovered the ESR1 gene polymorphisms are associated with decreased BMD and osteoporosis. The results on the BD-RT (bone density estimated by T-score at distal radius), three SNPs (rs2248586, rs9371557, and rs1569788) within the ESR1 gene were significantly associated with bone density. The results on the BD-TT (bone density estimated by T-score at midshaft tibia), five SNPs (rs9371552, rs2248586, rs712221, rs7772475, and rs3798577) were significantly associated with bone density. The SNP rs2248586 within the ESR1 gene had commonly significance in both BD-RT (${\beta}$=-0.151, dominant P=0.049) and BD-TT (${\beta}$=-0.156, dominant P=0.039). In the SNP rs2248586, their ${\beta}$-values in BD-RT and/or BD-TT showed consistent trends with the odds ratios (ORs) of osteoporosis. In summary, we found statistically significant SNPs in ESR1 gene that are associated with both decreased BMD and osteoporosis traits. Therefore, our findings suggest ESR1 gene could be related to pathogenesis of osteoporosis.

Keywords

References

  1. Albagha OM, Ralston SH. Genetics and osteoporosis. Rheum Dis Clin North Am. 2006. 32: 659-680. https://doi.org/10.1016/j.rdc.2006.08.001
  2. Barrett JG, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005. 21: 263-265. https://doi.org/10.1093/bioinformatics/bth457
  3. Bechereni L, Gennari L, Masi L, Mansani R, Massart F, Morelli A, Falchetti A, Gonnelli S, Fiorelli G, Tanini A, Brandi ML. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet. 2000. 9: 2043-2050. https://doi.org/10.1093/hmg/9.13.2043
  4. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, Cha SH, Kim JW, Han BG, Min H, Ahn Y, Park MS, Han HR, Jang HY, Cho EY, Lee JE, Cho NH, Shin C, Park T, Park JW, Lee JK, Cardon L, Clarke G, McCarthy MI, Lee JY, Oh B, Kim HL. A large-scale genomewide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009. 41: 527-534. https://doi.org/10.1038/ng.357
  5. Cole RE. Improving clinical decisions for women at risk of osteoporosis: dual-femur bone mineral density testing. J Am Osteopath Assoc. 2008. 108: 289-295.
  6. Colin E, Uitterlinden A, Meurs J, Bergink AP, van de Klift M, Fang Y, Arp PP, Hofman A, van Leeuwen JP, Pols HA. Interaction between vitamin D receptor genotype and estrogen receptor alpha genotype influences vertebral fracture risk. J Clin Endocrinol Metab. 2003. 88: 3777-3784. https://doi.org/10.1210/jc.2002-021861
  7. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, Oei L, Albagha OM, Rivadeneira F. Genomewide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012. 44: 491-501. https://doi.org/10.1038/ng.2249
  8. Francesco M, Francesca M, Gerolamo B, Salvatore M, Giovanni L, Antonella P, Sara S, Dino M, Laura M, Maria LB. Age-specific effects of estrogen receptor's polymorphisms on the bone traits in healthy fertile women: the BONTURNO study. Reprod Biol Endocrinol. 2009. 7: 1186-1193.
  9. Gennari L, Becherini L, Masi L, Mansani R, Gonnelli S, Cepollaro C, Martini S, Montagnani A, Lentini G, Becorpi AM, Brandi ML. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab. 1998. 83: 939-944. https://doi.org/10.1210/jc.83.3.939
  10. Harslof T, Husted LB, Carstens M, Stenkjaer L, Langdahl BL. Genotypes and haplotypes of the estrogen receptor genes, but not the retinoblastoma-interacting zinc finger protein 1 gene, are associated with osteoporosis. Calcif Tissue Int. 2010. 87: 25-35. https://doi.org/10.1007/s00223-010-9375-y
  11. Hedrick PW. Gametic disequilibrium measures: Proceed with caution. Genetics. 1987. 117: 331-341.
  12. Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, Albagha O, Ralston SH, Tsatsoulis A. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a metaanalysis. J Bone Miner Res. 2002. 17: 2048-2060. https://doi.org/10.1359/jbmr.2002.17.11.2048
  13. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, McGuigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE, Uitterlinden AG. GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA. 2004. 292: 2105-2114. https://doi.org/10.1001/jama.292.17.2105
  14. Kanis JA, Melton LJ, 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994. 9: 1137-1141.
  15. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int. 1997. 7: 390-406. https://doi.org/10.1007/BF01623782
  16. Karasawa T, Takahashi A, Saito R, Sekiya M, Igarashi M, Iwasaki H, Miyahara S, Koyasu S, Nakagawa Y, Ishii K, Matsuzaka T, Kobayashi K, Yahagi N, Takekoshi K, Sone H, Yatoh S, Suzuki H, Yamada N, Shimano H. Sterol regulatory elementbinding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2011. 31: 1788-1795. https://doi.org/10.1161/ATVBAHA.110.219659
  17. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res. 1996. 11: 306-311.
  18. Mahonen A, Turunen AM, Kroger H, Maempaa PH. Estrogen receptor gene polymorphism is associated with bone mineral density in perimenopausal Finnish women. J Bone Miner Res. 1997. 12: T614.
  19. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008. 9: 356-369. https://doi.org/10.1038/nrg2344
  20. Parker MG, Arbuckle N, Dauvois S, Danielian P, White R. Structure and function of the estrogen receptor. Ann NY Acad Sci. 1993. 684: 119-126. https://doi.org/10.1111/j.1749-6632.1993.tb32276.x
  21. Rabbee N, Speed TP. A genotype calling algorithm for Affymetrix SNP array. Bioinformatics. 2006. 22: 7-12. https://doi.org/10.1093/bioinformatics/bti741
  22. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008. 358: 2355-2365. https://doi.org/10.1056/NEJMoa0801197
  23. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Snorradorrir S, Center JR, Nguyen TV, Alexandersen P, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K. New sequence variants associated with bone mineral density. Nat Genet. 2009. 41: 15-17. https://doi.org/10.1038/ng.284
  24. van Meurs JB, Schuit SC, Weel AE, van der Klift M, Bergink AP, Arp PP, Colin EM, Fang Y, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG. Association of 5'-estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet. 2003. 12: 1745-1754. https://doi.org/10.1093/hmg/ddg176
  25. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E. Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int. 2001. 12: 271-278. https://doi.org/10.1007/s001980170116
  26. Williams FM, Spector TD. The genetics of osteoporosis. Acta Reumatol Port. 2007. 32: 231-240.
  27. Willing M, Sowers M, Aron D, Clark D, Burns T, Bunten C, Crutchfield M, D'Agostino D, Jannausch M. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res. 1998. 13: 695-705. https://doi.org/10.1359/jbmr.1998.13.4.695
  28. Yamada Y, Ando F, Niino N, Ohta S, Shimokata H. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density of the femoral neck in elderly Japanese women. J Mol Med. 2002. 80: 452-460. https://doi.org/10.1007/s00109-002-0348-0
  29. Zayzafoon M, Botolin S, McCabe LR. P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. J Biol Chem. 2002. 277: 37212-37218. https://doi.org/10.1074/jbc.M200129200
  30. Zhang Y, Long J, Liu P, Liu YJ, Shen H, Zhao LJ, Deng HW. Estrogen receptor alpha and vitamin D receptor polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women. Biochem Biophys Res Commun. 2003. 308: 777-783. https://doi.org/10.1016/S0006-291X(03)01479-7